CTI Technology Gives Biodiesel Industry New Life --- CTI and DOW Chemical Are Jointly Conducting Trials for ALS to Implement New Third Generation Biodiesel Technology.
23 Sep 2009
LOS ANGELES, Sept. 23 /PRNewswire-FirstCall/ -- Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT & Berlin: WTC) is pleased to announce Biocombustibles y Energias Alternativas (ALS) has entered into a long-term agreement with CTI to develop projects in Argentina and throughout Latin America. ALS (www.alsbio.com), partnering with DOW Chemical (www.dow.com), has identified several projects where CTI technology can greatly improve process yields and profitability using CTI and DOW proprietary technology.
According to Roman Gordon, CTI CEO, "We are very pleased to be working with ALS and DOW on these projects and expect that there is a bright future for the combination of our technologies in Argentina as well as the rest of the world where older outdated technologies have been installed." Mr. Gordon went on further to say, "We are also very excited about the other applications for our technology in the wastewater, petroleum and chemical industries that DOW could have an interest in. We look forward to working with them. These first projects in Argentina represent 480,000 metric tons of fuel per year and more than a $2,500,000 in sales revenue for CTI."
About Cavitation Technologies
Cavitation Technologies, Inc. (CTI) (OTCBB: CVAT), a "Green-Tech" company, was established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage and chemical industries. For additional information please visit: www.cavitationtechnologies.com
Safe Harbor: Pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934, any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals and assumptions of future events or performance are not statements of historical fact and may be "forward-looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this release may be identified through the use of words such as "expects," "will," "anticipates," "estimates," "believes," or statements indicating certain actions such as "may," "could," or "might" occur. Such statements reflect the current views of CTI with respect to future events and are subject to certain assumptions, including those described in this release. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services, and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. Cavitation Technologies, Inc. does not undertake any responsibility to update the "forward-looking" statements contained in this news release.